Since melanoma growth is partially regulated via podoplanin-CLEC-2 mediated platelet aggregation, SZ168 is thought to suppress tumor growth by inhibiting the interaction between tumor podoplanin and platelet CLEC-2 [97]. Here, CLEC1B is linked to neoplasm.